Will A CV Warning On Meridia Alter FDA Views On Obesity Drugs?
This article was originally published in The Pink Sheet Daily
Executive Summary
The diet pill was not approved or recommended for use in about 90 percent of patients in the trial that triggers the warning, Abbott says.